PARTNERING
Join an elevated partnership
Elevar Therapeutics is dedicated to elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, as well as expanding access to bring therapies to more patients in more geographies.
Partnership is part of our culture, with highly engaged and diverse teams coming together for a shared purpose: to bring life-changing treatments to more patients.
Elevar is interested in partnerships for the successful development and commercialization of therapies. Click to connect with us.
EXISTING PARTNERSHIPS
PARTNERSHIP CONTACT
WADE SMITH
Chief Financial Officer
With more than 20 years of experience as a financial executive, Wade Smith joined Elevar Therapeutics as our Chief Financial Officer in January 2022 after spending the previous decade at Viatris (formerly Mylan Pharmaceuticals), a global health care company working in a broad range of therapeutic areas. Wade was Viatris’ head of U.S. institutional commercial/finance from 2017-2022, functioning as the COO and CFO for the $1 billion+ division. He developed a go-to-market strategy for more than 100 new products, overseeing launch pricing, customer contracting, managed care engagement and sales targeting in addition to portfolio selection and budgeting/forecasting.
ELEVAR CORPORATE PRESENTATION
Interested in partnering with Elevar?
Let’s get in touch
